Blog

Articles, guides, and regulatory updates from our community.

All Clinical Applications Longevity Peptide Basics Provider Resources Research & Science Safety & Regulation Weight Management

503A 503B 503a compounding peptide Alzheimer's disease Anti-Aging BPC-157 Bremelanotide CJC-1295 Circadian Compliance Compounding Copper Peptide DSIP Epitalon Evidence Review FDA FDA Approved FDA approval GHK peptide GHK-Cu GI GLP-1 GLP-1 agonists Getting Started Growth Hormone Gut Health Healing Hippo-YAP pathway Humanin IBS IL-15 Immune Support Immunology Ipamorelin KPV Larazotide Longevity MOTS-c Melanocortin Mitochondria NAD+Obesity PT-141 Patient Education Peptide Basics Pharmacy Provider Guide Quality REST protein Recovery Regulation Research SIRT1 SS-31 SS-31 peptide Safety Semaglutide Sexual Health Side Effects Skin Health Sleep Tesamorelin Thymosin Alpha-1 Tirzepatide Weight Management adipose tissue alzheimers alzheimers-disease alzheimers-research antidiabetic drugs antidiabetic-drugs antioxidant peptides athletic performance bpc 157 anti-inflammatory bpc 157 dosage bpc 157 gut healing bpc 157 joint repair brain aging brain health cancer research cancer treatment carbonless peptides cardiac health cardioprotection cardiotoxicity cardiovascular disease cepharanthine chemotherapy childhood obesity clinical research clinical-research cognitive function compounded peptide safety computational chemistry cost-effectiveness diabetes dihexa peptide doxorubicin drug stability drug-repurposing dry eye research elamipretide environmental factors environmental health evidence-based medicine exposome research fat burning formulation science global health global health study healthcare economics healthcare-economics heart protection hepatitis-b hepatocellular carcinoma immune peptide therapy immune-system immunotherapy injectable peptides liposomal delivery liposome delivery liposomes liver-cancer liver-failure longevity peptide research manufacturing metabolic medicine metal binding mitochondria mitochondrial health mitochondrial peptide mitochondrial peptides mitochondrial therapy mitochondrial-dysfunction mitochondrial-health mitochondrial-therapy mots-c longevity musculoskeletal injuries nad peptide therapy natural compound therapy neurodegeneration neurodegenerative-disease neurological health neuroprotection neuroscience obesity research pediatric health peptide delivery system peptide for tendon repair peptide research peptide safety peptide therapy peptide therapy anxiety peptide therapy brain peptide therapy doctor near me peptide therapy healing peptide therapy side effects peptide-research pharmaceutical research precision-medicine probiotic therapy regulatory compliance regulatory oversight retatrutide retatrutide weight loss selank peptide benefits semax cognitive enhancement semax peptide cognitive sports medicine ss-31 elamipretide ss-31 mitochondria sustained release peptide systematic review systematic-review tb4 peptide therapy therapeutic-research therapeutic-strategies thermogenesis thymosin alpha 1 cancer thymosin alpha 1 immune thymosin alpha hepatitis thymosin beta 4 injury thymosin-alpha-1 type 2 diabetes

Showing 3 articles tagged SS-31Clear filters

Apr 23, 20264 min read

Research & Science

New Research Shows Peptide SS-31 May Protect Heart

Recent study reveals how mitochondria-targeted peptide SS-31 could help prevent heart damage from cancer treatment. Learn about this promising research.

SS-31cardiotoxicitymitochondrial peptides+3

By Peptide Association Research Team

Apr 22, 20263 min read

Safety & Regulation

New Research: SS-31 Peptide Targets Fat Cell Mitochondria

Recent 2026 study shows SS-31 peptide in targeted liposomes may improve mitochondrial function in fat cells. Animal research suggests potential for obesity treatment.

SS-31mitochondriaadipose tissue+2

By Peptide Association Research Team

Apr 22, 20264 min read

Research & Science

Study: Antioxidant Peptide SS-31 Shows Promise in Research

New research explores how the mitochondria-targeted antioxidant peptide SS-31 may help protect cardiac function in laboratory studies of doxorubicin toxicity.

SS-31mitochondriacardioprotection+4

By Peptide Association Research Team